JP2015523060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523060A5 JP2015523060A5 JP2015512688A JP2015512688A JP2015523060A5 JP 2015523060 A5 JP2015523060 A5 JP 2015523060A5 JP 2015512688 A JP2015512688 A JP 2015512688A JP 2015512688 A JP2015512688 A JP 2015512688A JP 2015523060 A5 JP2015523060 A5 JP 2015523060A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- pharmaceutical composition
- sequence
- human subject
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261647461P | 2012-05-15 | 2012-05-15 | |
| US61/647,461 | 2012-05-15 | ||
| US201261670535P | 2012-07-11 | 2012-07-11 | |
| US61/670,535 | 2012-07-11 | ||
| US201261678555P | 2012-08-01 | 2012-08-01 | |
| US61/678,555 | 2012-08-01 | ||
| US201261691660P | 2012-08-21 | 2012-08-21 | |
| US61/691,660 | 2012-08-21 | ||
| US201361775440P | 2013-03-08 | 2013-03-08 | |
| US61/775,440 | 2013-03-08 | ||
| PCT/US2013/040011 WO2013173129A2 (en) | 2012-05-15 | 2013-05-07 | Treatment of amd using aav sflt-1 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017209139A Division JP6667486B2 (ja) | 2012-05-15 | 2017-10-30 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523060A JP2015523060A (ja) | 2015-08-13 |
| JP2015523060A5 true JP2015523060A5 (https=) | 2017-04-20 |
| JP6466322B2 JP6466322B2 (ja) | 2019-02-06 |
Family
ID=49584435
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512688A Active JP6466322B2 (ja) | 2012-05-15 | 2013-05-07 | Ａａｖｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2017209139A Active JP6667486B2 (ja) | 2012-05-15 | 2017-10-30 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2019028448A Withdrawn JP2019071908A (ja) | 2012-05-15 | 2019-02-20 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2020209916A Withdrawn JP2021045170A (ja) | 2012-05-15 | 2020-12-18 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2022077005A Withdrawn JP2022106929A (ja) | 2012-05-15 | 2022-05-09 | Ａａｖ ｓｆｌｔ－１を用いたａｍｄの処置 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017209139A Active JP6667486B2 (ja) | 2012-05-15 | 2017-10-30 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2019028448A Withdrawn JP2019071908A (ja) | 2012-05-15 | 2019-02-20 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2020209916A Withdrawn JP2021045170A (ja) | 2012-05-15 | 2020-12-18 | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 |
| JP2022077005A Withdrawn JP2022106929A (ja) | 2012-05-15 | 2022-05-09 | Ａａｖ ｓｆｌｔ－１を用いたａｍｄの処置 |
Country Status (27)
| Country | Link |
|---|---|
| US (7) | US20130323302A1 (https=) |
| EP (3) | EP2849802B1 (https=) |
| JP (5) | JP6466322B2 (https=) |
| KR (3) | KR20210021111A (https=) |
| CN (2) | CN104994882A (https=) |
| AU (3) | AU2013263159B2 (https=) |
| BR (1) | BR112014028633A8 (https=) |
| CA (1) | CA2873628C (https=) |
| CY (1) | CY1124495T1 (https=) |
| DK (1) | DK3501549T3 (https=) |
| ES (2) | ES2890813T3 (https=) |
| HR (1) | HRP20211453T1 (https=) |
| HU (1) | HUE056327T2 (https=) |
| IL (2) | IL235679B (https=) |
| LT (1) | LT3501549T (https=) |
| MX (2) | MX362452B (https=) |
| NZ (2) | NZ727516A (https=) |
| PL (1) | PL3501549T3 (https=) |
| PT (1) | PT3501549T (https=) |
| RS (1) | RS62359B1 (https=) |
| RU (1) | RU2014150340A (https=) |
| SG (2) | SG10201609412QA (https=) |
| SI (1) | SI3501549T1 (https=) |
| SM (1) | SMT202100549T1 (https=) |
| TW (3) | TWI698240B (https=) |
| WO (1) | WO2013173129A2 (https=) |
| ZA (1) | ZA201409025B (https=) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| CN105755044A (zh) | 2011-04-22 | 2016-07-13 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体及其使用方法 |
| TWI698240B (zh) | 2012-05-15 | 2020-07-11 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
| US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
| EP3003391B1 (en) | 2013-05-31 | 2021-09-22 | The Regents of The University of California | Adeno-associated virus variants and methods of use thereof |
| KR101591823B1 (ko) | 2013-12-27 | 2016-02-04 | 재단법인 목암생명공학연구소 | 증가된 유전자 발현능을 갖는 발현벡터 |
| BR112016017817A2 (pt) * | 2014-02-06 | 2017-10-10 | Genzyme Corp | composições e métodos para o tratamento e a prevenção de degeneração macular |
| GB201403684D0 (en) | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| EP3800191B1 (en) | 2014-03-17 | 2025-08-20 | Adverum Biotechnologies, Inc. | Compositions and methods for enhanced gene expression in cone cells |
| US20170143848A1 (en) * | 2014-03-24 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Mrna therapy for the treatment of ocular diseases |
| WO2015153889A2 (en) * | 2014-04-02 | 2015-10-08 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| LT3137497T (lt) | 2014-05-02 | 2021-07-26 | Genzyme Corporation | Aav vektoriai, skirti tinklainės ir cns genų terapijai |
| EP3151866B1 (en) | 2014-06-09 | 2023-03-08 | Voyager Therapeutics, Inc. | Chimeric capsids |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| RU2716991C2 (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| GB201502137D0 (en) * | 2015-02-09 | 2015-03-25 | Ucl Business Plc | Treatment |
| US11021519B2 (en) | 2015-03-02 | 2021-06-01 | Adverum Biotechnologies, Inc. | Compositions and methods for intravitreal delivery of polynucleotides to retinal cones |
| EP3748007B1 (en) * | 2015-03-06 | 2024-06-26 | Massachusetts Eye & Ear Infirmary | Gene augmentation therapies for inherited retinal degeneration caused by mutations in the prpf31 gene |
| JP6836999B2 (ja) | 2015-03-24 | 2021-03-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | アデノ随伴ウイルス変異体及びその使用方法 |
| EP3294890A4 (en) * | 2015-05-08 | 2018-10-03 | Children's Medical Research Institute | Promoters for expression of heterologous genes |
| EP3294309A4 (en) * | 2015-05-14 | 2019-01-16 | St. Jude Children's Research Hospital, Inc. | NUCLEIC ACID MOLECULES WITH SPACERS AND METHOD FOR USE THEREOF |
| US10016514B2 (en) | 2015-05-15 | 2018-07-10 | New Hope Research Foundation | Polynucleotides, vectors and methods for insertion and expression of transgenes |
| CA3001594A1 (en) * | 2015-10-14 | 2017-04-20 | Audentes Therapeutics, Inc. | Nucleic acid molecules containing spacers and methods of use thereof |
| WO2017075335A1 (en) | 2015-10-28 | 2017-05-04 | Voyager Therapeutics, Inc. | Regulatable expression using adeno-associated virus (aav) |
| GB201519086D0 (en) * | 2015-10-28 | 2015-12-09 | Syncona Partners Llp | Gene Therapy |
| EP3383439B1 (en) * | 2015-12-03 | 2019-09-25 | Friedrich Miescher Institute for Biomedical Research | Synp161, a promoter for the specific expression of genes in rod photoreceptors |
| GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
| KR20250057128A (ko) | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| SG11201808426XA (en) * | 2016-04-15 | 2018-10-30 | Univ Pennsylvania | Compositions for treatment of wet age-related macular degeneration |
| KR20240005973A (ko) * | 2016-04-15 | 2024-01-12 | 리젠엑스바이오 인크. | 완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료 |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| US20170319669A1 (en) * | 2016-05-03 | 2017-11-09 | Wayne State University | Method of enhancing viral-mediated gene delivery |
| KR102427379B1 (ko) | 2016-05-18 | 2022-08-02 | 보이저 테라퓨틱스, 인크. | 헌팅톤 질환을 치료하기 위한 조성물 및 방법 |
| KR20240056729A (ko) | 2016-05-18 | 2024-04-30 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| ES2840059T3 (es) * | 2016-06-16 | 2021-07-06 | Adverum Biotechnologies Inc | Tratamiento de la DMRE mediante el uso de la variante AAV2 con aflibercept |
| KR20190038536A (ko) * | 2016-06-16 | 2019-04-08 | 애드베룸 바이오테크놀로지스, 인코포레이티드 | 안구 혈관신생을 저하시키기 위한 조성물 및 방법 |
| AU2017302013B2 (en) | 2016-07-29 | 2022-05-26 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| WO2018044933A1 (en) | 2016-08-30 | 2018-03-08 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| CA3040179A1 (en) | 2016-10-19 | 2018-04-26 | Adverum Biotechnologies, Inc. | Modified aav capsids and uses thereof |
| CN107058315B (zh) * | 2016-12-08 | 2019-11-08 | 上海优卡迪生物医药科技有限公司 | 敲减人PD-1的siRNA、重组表达CAR-T载体及其构建方法和应用 |
| KR102738752B1 (ko) * | 2016-12-30 | 2024-12-06 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 페닐케톤뇨증을 치료하기 위한 유전자 치료 |
| WO2018170494A1 (en) * | 2017-03-16 | 2018-09-20 | Bio Time, Inc. | Methods for measuring therapeutic effects of retinal disease therapies |
| EP4653536A3 (en) * | 2017-03-17 | 2026-02-25 | Adverum Biotechnologies, Inc. | Compositions and methods for enhanced gene expression |
| JP2020518258A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 筋萎縮性側索硬化症（ａｌｓ）治療組成物および方法 |
| JP2020518259A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ハンチントン病治療組成物および方法 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CA3053154A1 (en) | 2017-06-30 | 2019-01-03 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsids and methods of use thereof |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CA3070087A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| JP2020534788A (ja) | 2017-08-28 | 2020-12-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | アデノ随伴ウイルスカプシド変異体及びその使用方法 |
| EP3687464A4 (en) * | 2017-09-27 | 2021-09-29 | REGENXBIO Inc. | TREATMENT OF EYE DISEASES WITH A TOTALLY HUMAN POST-TRANSLATION MODIFIED ANTI-VEGF FAB |
| AU2018338728B2 (en) | 2017-09-29 | 2025-01-02 | Centre National De La Recherche Scientifique (Cnrs) | Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| KR102205830B1 (ko) * | 2017-10-26 | 2021-01-21 | 주식회사 큐로진생명과학 | 솔루블 VEGFR-1 변이체 cDNA를 함유하는 rAAV를 포함하는 황반변성 치료용 조성물 |
| EP3727468A4 (en) * | 2017-12-19 | 2021-09-22 | Akouos, Inc. | AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR |
| US10610606B2 (en) * | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| US12558434B2 (en) | 2018-02-20 | 2026-02-24 | The Trustees Of The University Of Pennsylvania | Compositions for treatment of wet age-related macular degeneration |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| EP3762500A1 (en) | 2018-03-06 | 2021-01-13 | Voyager Therapeutics, Inc. | Insect cell manufactured partial self-complementary aav genomes |
| AU2019265663B2 (en) * | 2018-05-08 | 2024-06-13 | Rutgers, The State University Of New Jersey | AAV-compatible laminin-linker polymerization proteins |
| DK4364724T3 (da) | 2018-05-10 | 2025-12-22 | Regeneron Pharma | Formuleringer med høj koncentration af VEGF-receptorfusionsprotein |
| KR20210019996A (ko) | 2018-05-15 | 2021-02-23 | 보이저 테라퓨틱스, 인크. | 파킨슨병의 치료를 위한 조성물 및 방법 |
| US20210214749A1 (en) | 2018-05-16 | 2021-07-15 | Voyager Therapeutics, Inc. | Directed evolution |
| US20210207167A1 (en) | 2018-05-16 | 2021-07-08 | Voyager Therapeutics, Inc. | Aav serotypes for brain specific payload delivery |
| CA3103231A1 (en) * | 2018-06-11 | 2019-12-19 | Serge FITOUSSI | Recombinant aav vectors and methods of using the same |
| US20210254103A1 (en) | 2018-07-02 | 2021-08-19 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
| CN112770812A (zh) | 2018-07-24 | 2021-05-07 | 沃雅戈治疗公司 | 产生基因治疗制剂的系统和方法 |
| EP3856762A1 (en) | 2018-09-28 | 2021-08-04 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| WO2020072849A1 (en) | 2018-10-04 | 2020-04-09 | Voyager Therapeutics, Inc. | Methods for measuring the titer and potency of viral vector particles |
| WO2020112853A1 (en) | 2018-11-28 | 2020-06-04 | Genascence Corporation | Methods and compositions for treating osteoarthritis |
| WO2020136384A1 (en) * | 2018-12-28 | 2020-07-02 | Constable Ian Jeffery | Methods of retinal administration |
| SG11202107645RA (en) | 2019-01-18 | 2021-08-30 | Voyager Therapeutics Inc | Methods and systems for producing aav particles |
| JP7597380B2 (ja) | 2019-03-04 | 2024-12-10 | アドヴェラム バイオテクノロジーズ， インコーポレイテッド | 対側眼へのａａｖ遺伝子治療の逐次的硝子体内投与 |
| TW202532428A (zh) | 2019-04-26 | 2025-08-16 | 美商愛德維仁生物科技公司 | 用於玻璃體內遞送之變異體aav蛋白殼 |
| EP3962536A1 (en) | 2019-04-29 | 2022-03-09 | Voyager Therapeutics, Inc. | Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| EP4010465A1 (en) | 2019-08-09 | 2022-06-15 | Voyager Therapeutics, Inc. | Cell culture medium for use in producing gene therapy products in bioreactors |
| EP4022070A1 (en) | 2019-08-26 | 2022-07-06 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
| AU2020346062A1 (en) * | 2019-09-13 | 2022-03-24 | Rutgers, The State University Of New Jersey | AAV-compatible laminin-linker polymerization proteins |
| BR112022005148A2 (pt) * | 2019-09-20 | 2023-02-23 | Meiragtx Therapeutics Inc | Sistemas de injeção e métodos de uso dos mesmos |
| CN112552410A (zh) * | 2019-09-26 | 2021-03-26 | 三生国健药业（上海）股份有限公司 | 一种抗体融合蛋白及其制法和在抗肿瘤中的应用 |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| US12611436B2 (en) | 2019-10-17 | 2026-04-28 | Sarepta Therapeutics, Inc. | AAV transfer cassette |
| AU2020396699B2 (en) * | 2019-12-04 | 2024-07-18 | Cdmogen Co., Ltd | Composition for treating diabetic retinopathy, comprising rAAV containing soluble VEGFR-1 variant cDNA |
| US20230181686A1 (en) * | 2020-05-27 | 2023-06-15 | Baylor College Of Medicine | Compositions and methods for treating neovascularization and ischemic retinopathies by targeting angiogenesis and cholesterol transport |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| CN113952473A (zh) * | 2020-07-21 | 2022-01-21 | 英斯培瑞有限公司 | 用于治疗眼部疾病的组合物和方法 |
| WO2022032153A1 (en) | 2020-08-06 | 2022-02-10 | Voyager Therapeutics, Inc. | Cell culture medium for use in producing gene therapy products in bioreactors |
| KR102775781B1 (ko) * | 2020-10-13 | 2025-03-06 | 재단법인 아산사회복지재단 | Acta2 억제제를 유효성분으로 포함하는 망막 또는 맥락막 질환 치료용 조성물 |
| IL303317A (en) | 2020-12-01 | 2023-07-01 | Akouos Inc | ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA |
| US20220267795A1 (en) * | 2021-02-24 | 2022-08-25 | Kinase Pharma Inc. | Compositions and methods for regulating production of an angiogensis inhibitor |
| WO2022187473A2 (en) | 2021-03-03 | 2022-09-09 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
| WO2022187548A1 (en) | 2021-03-03 | 2022-09-09 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
| US20240252679A1 (en) | 2021-05-28 | 2024-08-01 | Shanghai Regenelead Therapies Co., Ltd. | Recombinant adeno-associated virus having variant capsid, and application thereof |
| WO2023206134A1 (en) * | 2022-04-27 | 2023-11-02 | Beijing Sightnovo Medical Technology Co., Ltd | Compositions and methods for eye diseases |
| US20260085328A1 (en) | 2022-09-08 | 2026-03-26 | Voyager Therapeutics, Inc. | Controlled expression of viral proteins |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025019458A2 (en) * | 2023-07-14 | 2025-01-23 | The Trustees Of Columbia University In The City Of New York | Specific blood retinal barrier defect in glaucoma directs new treatments and clinical tests |
| CN120060370A (zh) | 2023-11-29 | 2025-05-30 | 上海科锐克医药科技有限公司 | 用于递送人vegf受体融合蛋白的基因递送载体及其应用 |
| US20250276095A1 (en) * | 2024-03-04 | 2025-09-04 | Kate Therapeutics, Inc. | Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy |
| CN118291541B (zh) * | 2024-06-05 | 2024-08-06 | 上海凌医生物科技有限公司 | 一种诱导型启动子 |
Family Cites Families (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4874237A (en) | 1987-05-07 | 1989-10-17 | Lions Eye Inst. Of Western Australia | Electroretinogram apparatus |
| JP2755817B2 (ja) | 1988-11-14 | 1998-05-25 | アメリカ合衆国 | パルボウイルスキャプシド |
| FR2643252B1 (fr) | 1989-02-21 | 1991-06-07 | Technomed Int Sa | Appareil de destruction selective de cellules incluant les tissus mous et les os a l'interieur du corps d'un etre vivant par implosion de bulles de gaz |
| US5112946A (en) | 1989-07-06 | 1992-05-12 | Repligen Corporation | Modified pf4 compositions and methods of use |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US6379885B1 (en) | 1989-09-14 | 2002-04-30 | Rijksuniversiteit Te Leiden | Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| IE913929A1 (en) | 1990-11-13 | 1992-05-20 | Immunex Corp | Bifunctional selectable fusion genes |
| US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
| CA2158745C (en) | 1993-03-25 | 2007-06-19 | Richard L. Kendall | Inhibitor of vascular endothelial cell growth factor |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| EP0745134A1 (en) | 1994-02-22 | 1996-12-04 | Danafarber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| FR2718150B1 (fr) | 1994-03-29 | 1996-04-26 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
| US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
| US5527533A (en) * | 1994-10-27 | 1996-06-18 | Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
| US20020168342A1 (en) | 1994-11-03 | 2002-11-14 | Cell Genesys, Inc. | Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| US6040183A (en) | 1995-06-07 | 2000-03-21 | University Of North Carloina At Chapel Hill | Helper virus-free AAV production |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US5641749A (en) | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| WO1998007435A1 (en) * | 1996-08-20 | 1998-02-26 | The Regents Of The University Of California | Eye treatments using synthetic thyroid hormone compositions |
| ATE343400T1 (de) | 1996-09-24 | 2006-11-15 | Merck & Co Inc | Verbindungen zur hemmung der angiogenese durch gentherapie |
| FR2756297B1 (fr) | 1996-11-22 | 1999-01-08 | Centre Nat Rech Scient | Procede de production de virus recombinants |
| US6153436A (en) | 1997-01-10 | 2000-11-28 | The Board Of Trustees Of The University Of Arkansas | Method of gene delivery using wildtype adeno associated viral (AAV) vectors with insertions |
| US6548286B1 (en) | 1997-04-14 | 2003-04-15 | Cell Genesys, Inc. | Methods for increasing the efficiency of recombinant AAV product |
| EP1173191A4 (en) | 1997-05-13 | 2004-12-01 | Univ California | NEW ANTIANGIOGENIC PEPTIDAGENTS AND THEIR THERAPEUTIC AND DIAGNOSTIC USE |
| US6458157B1 (en) * | 1997-08-04 | 2002-10-01 | Suaning Gregg Joergen | Retinal stimulator |
| WO1999014354A1 (en) | 1997-09-19 | 1999-03-25 | The Trustees Of The University Of The Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
| JPH11100327A (ja) | 1997-09-26 | 1999-04-13 | Toray Ind Inc | 網膜変性症治療剤 |
| CA2303401A1 (en) | 1997-10-01 | 1999-04-08 | G.D. Searle & Co. | Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| WO1999036511A2 (en) | 1998-01-16 | 1999-07-22 | Chiron Corporation | Feline immunodeficiency virus gene therapy vectors |
| ATE226444T1 (de) | 1998-03-12 | 2002-11-15 | Genentech Inc | Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten |
| US6593133B1 (en) | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| WO2000012740A2 (en) * | 1998-08-28 | 2000-03-09 | Duke University | ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES |
| CA2346262A1 (en) | 1998-09-17 | 2000-03-23 | University Of Florida | Methods for treatment of degenerative retinal diseases |
| US20040234505A1 (en) | 1998-09-23 | 2004-11-25 | Stuart Naylor | Polynucleotide constructs and uses thereof |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| AU3755900A (en) * | 1999-03-15 | 2000-10-04 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US7306799B2 (en) * | 1999-06-08 | 2007-12-11 | Regeneron Pharmaceuticals, Inc. | Use of VEGF inhibitors for treatment of eye disorders |
| US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
| JP2003513691A (ja) | 1999-10-25 | 2003-04-15 | シーラス、コーポレイション | 血管を封止するための集束超音波の使用 |
| EP1274339B1 (en) | 2000-04-17 | 2011-06-08 | The University of Sydney | Method for objective electrophysiological assessment of visual function |
| US6329181B1 (en) | 2000-08-07 | 2001-12-11 | Neurologix, Inc. | Helper functions for recombinant vector production |
| CA2437563C (en) * | 2001-02-06 | 2010-03-23 | Qlt Inc. | Photodynamic therapy of occult age-related macular degeneration |
| US20040102765A1 (en) | 2001-03-27 | 2004-05-27 | Karsten Koenig | Method for the minimal-to non-invase optical treatment of tissues of the eye and for diagnosis thereof and device for carrying out said method |
| WO2002082904A2 (en) | 2001-04-13 | 2002-10-24 | The Trustees Of The University Of Pennsylvania | Method of treating or retarding the development of blindness |
| JP2002363107A (ja) | 2001-06-04 | 2002-12-18 | Noriyuki Azuma | 色覚不全動物の色覚復元方法 |
| ATE527347T1 (de) | 2001-08-02 | 2011-10-15 | Inst Clayton De La Rech | Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| WO2003080648A2 (en) | 2002-03-20 | 2003-10-02 | University Of Florida Research Foundation, Inc. | Raav vector compositions and methods for the treatment of choroidal neovascularization |
| US7858367B2 (en) | 2002-04-30 | 2010-12-28 | Duke University | Viral vectors and methods for producing and using the same |
| US8304233B2 (en) | 2002-06-04 | 2012-11-06 | Poetic Genetics, Llc | Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| AU2003265855A1 (en) | 2002-08-28 | 2004-03-19 | University Of Florida | Modified aav |
| GB0220467D0 (en) | 2002-09-03 | 2002-10-09 | Oxford Biomedica Ltd | Composition |
| US20100144038A1 (en) | 2003-03-04 | 2010-06-10 | Masato Miyake | Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US20060166363A1 (en) | 2004-01-27 | 2006-07-27 | Sergei Zolotukhin | Modified baculovirus expression system for production of pseudotyped rAAV vector |
| PT2229956E (pt) | 2004-09-13 | 2013-07-31 | Genzyme Corp | Contruções multiméricas |
| PT1802334E (pt) * | 2004-10-21 | 2012-11-28 | Genentech Inc | Método para tratamento de doenças neovasculares intraoculares |
| ES2384391T3 (es) | 2004-11-08 | 2012-07-04 | Chromagenics B.V. | Selección de células hospedantes que expresan proteína a altos niveles |
| US7922670B2 (en) | 2005-02-24 | 2011-04-12 | Warren Jones | System and method for quantifying and mapping visual salience |
| ES2525067T3 (es) | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| US20060234347A1 (en) | 2005-04-13 | 2006-10-19 | Harding Thomas C | Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| EP2311966A3 (en) | 2005-10-20 | 2012-09-05 | Amsterdam Molecular Therapeutics (AMT) B.V. | Improved AAV vectors produced in insect cells |
| WO2007084773A2 (en) | 2006-01-20 | 2007-07-26 | University Of North Carolina At Chapel Hill | Enhanced production of infectious parvovirus vectors in insect cells |
| US20070190028A1 (en) | 2006-02-13 | 2007-08-16 | Jihong Qu | Method and apparatus for heat or electromagnetic control of gene expression |
| US7384145B2 (en) | 2006-02-16 | 2008-06-10 | The Board Of Trustees Of The University Of Illinois | Mapping retinal function using corneal electrode array |
| US8118752B2 (en) | 2006-02-16 | 2012-02-21 | The Board Of Trustees Of The University Of Illinois | Apparatus and methods for mapping retinal function |
| US8216575B2 (en) * | 2006-03-31 | 2012-07-10 | Chengdu Kanghong Biotechnologies Co., Ltd. | Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains |
| WO2007128526A2 (en) * | 2006-05-04 | 2007-11-15 | Fovea Pharmaceuticals Sa | Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| DK2029746T3 (da) * | 2006-06-12 | 2012-10-08 | Exegenics Inc D B A Opko Health Inc | Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese |
| GB0612096D0 (en) | 2006-06-19 | 2006-07-26 | Greater Glasgow Nhs Board | Functional imaging of the retina |
| CN103849629B (zh) | 2006-06-21 | 2017-06-09 | 尤尼克尔Ip股份有限公司 | 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体 |
| KR100922422B1 (ko) | 2006-06-27 | 2009-10-16 | 가부시키가이샤 어드밴테스트 | 반도체 시험 장치 및 반도체 메모리의 시험 방법 |
| WO2008024998A2 (en) | 2006-08-24 | 2008-02-28 | Virovek, Inc. | Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor |
| WO2008098310A1 (en) | 2007-02-16 | 2008-08-21 | Objectivision Limited | Stimulus method for multifocal visual evoked potential |
| EP1995309A1 (en) | 2007-05-21 | 2008-11-26 | Vivalis | Recombinant protein production in avian EBx® cells |
| WO2008150459A1 (en) | 2007-05-30 | 2008-12-11 | The Trustees Of The University Of Pennsylvania | A method for transducing cells with primary cilia |
| WO2009023805A1 (en) | 2007-08-16 | 2009-02-19 | The Research Foundation Of State University Of New York | Led variable light source |
| US8518037B2 (en) | 2007-10-30 | 2013-08-27 | Boston Scientific Scimed, Inc. | Radiofrequency ablation device |
| US20110053274A1 (en) | 2007-11-30 | 2011-03-03 | Scarab Genomics Llc | Lac expression system |
| JP2011512156A (ja) | 2008-02-19 | 2011-04-21 | アムステルダム モレキュラー セラピューティクス ビー．ブイ． | 昆虫細胞におけるパルボウイルスｒｅｐ及びｃａｐタンパク質の発現の最適化 |
| CN101951925A (zh) | 2008-02-20 | 2011-01-19 | 建新公司 | 血管发生抑制 |
| US20100081707A1 (en) * | 2008-02-21 | 2010-04-01 | Ali Robin R | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| ITFI20080081A1 (it) | 2008-04-18 | 2009-10-19 | Strumenti Oftalmici C S O S R | Procedimento e sistema per la registrazione di risposte elettrofunzionali erg, perg e vep multifocali in tempo reale |
| WO2009137006A2 (en) | 2008-04-30 | 2009-11-12 | The University Of North Carolina At Chapel Hill | Directed evolution and in vivo panning of virus vectors |
| ES2330826B1 (es) | 2008-06-04 | 2010-07-26 | Proyecto De Biomedicina Cima, S.L. | Sistema para empaquetamiento de adenovirus de alta capacidad. |
| ES2742180T3 (es) | 2009-03-04 | 2020-02-13 | Deutsches Krebsforsch | Proteína activadora del ensamblaje (AAP) y su uso para la fabricación de partículas de parvovirus que consisten esencialmente en VP3 |
| WO2010114948A2 (en) | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors |
| TWI466158B (zh) | 2009-07-03 | 2014-12-21 | Univ Lunghwa Sci & Technology | 電漿測量裝置、電漿系統及測量電漿特性之方法 |
| EP2287323A1 (en) * | 2009-07-31 | 2011-02-23 | Association Institut de Myologie | Widespread gene delivery to the retina using systemic administration of AAV vectors |
| EP2292781A1 (en) | 2009-08-17 | 2011-03-09 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
| US20120172419A1 (en) | 2009-09-15 | 2012-07-05 | Medical College Of Wisconsin Research Foundation Inc. | Reagents and methods for modulating cone photoreceptor activity |
| US20110270256A1 (en) | 2009-09-24 | 2011-11-03 | Medicinelodge, Inc. Dba Imds Co-Innovation | Surgical rasp with radiofrequency ablation |
| EP2524037B1 (en) | 2010-01-12 | 2018-05-16 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| EP2545165B1 (en) | 2010-03-11 | 2020-07-29 | uniQure IP B.V. | Mutated rep encoding sequences for use in aav production |
| WO2011126808A2 (en) | 2010-03-29 | 2011-10-13 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| WO2011122950A1 (en) | 2010-04-01 | 2011-10-06 | Amsterdam Molecular Therapeutics (Amt) Ip B.V. | Monomeric duplex aav vectors |
| CN201704771U (zh) | 2010-04-30 | 2011-01-12 | 陈福环 | 无水箱节水型抽水马桶 |
| EP2563395A4 (en) | 2010-04-30 | 2013-11-27 | Lpath Inc | TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| WO2012068317A2 (en) | 2010-11-16 | 2012-05-24 | Excelimmune, Inc. | Methods for producing recombinant proteins |
| CN103608455B (zh) | 2011-01-07 | 2019-01-15 | 应用遗传科技公司 | 用于治疗色盲和其它疾病的启动子、表达盒、载体、药盒和方法 |
| CN105755044A (zh) | 2011-04-22 | 2016-07-13 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体及其使用方法 |
| AU2012327236B2 (en) | 2011-10-28 | 2016-11-10 | University Of Florida Research Foundation, Inc. | Chimeric promoter for cone photoreceptor targeted gene therapy |
| TWI698240B (zh) | 2012-05-15 | 2020-07-11 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
| WO2013188316A1 (en) | 2012-06-11 | 2013-12-19 | Avalanche Biotechnologies, Inc. | Optical regulation of gene expression in the retina |
| WO2014207190A1 (en) | 2013-06-28 | 2014-12-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for expressing a polynucleotide of interest in the retina of a subject |
| US20150025939A1 (en) | 2013-07-18 | 2015-01-22 | Somnath Chatterjee | Company Centric Social Media Platfonn for Content Sharing aud Tracking |
| ES2739288T3 (es) | 2013-09-13 | 2020-01-30 | California Inst Of Techn | Recuperación selectiva |
| WO2015048534A1 (en) | 2013-09-26 | 2015-04-02 | University Of Florida Research Foundation, Inc. | Synthetic combinatorial aav capsid library for targeted gene therapy |
| EP3113787B1 (en) | 2014-03-04 | 2019-12-04 | University of Florida Research Foundation, Inc. | Improved raav vectors and methods for transduction of photoreceptors and rpe cells |
| EP3800191B1 (en) | 2014-03-17 | 2025-08-20 | Adverum Biotechnologies, Inc. | Compositions and methods for enhanced gene expression in cone cells |
| US11021519B2 (en) | 2015-03-02 | 2021-06-01 | Adverum Biotechnologies, Inc. | Compositions and methods for intravitreal delivery of polynucleotides to retinal cones |
| GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
-
2013
- 2013-05-06 TW TW107100972A patent/TWI698240B/zh active
- 2013-05-06 TW TW109119818A patent/TWI775096B/zh active
- 2013-05-06 TW TW102116146A patent/TWI702955B/zh active
- 2013-05-07 EP EP13791695.3A patent/EP2849802B1/en active Active
- 2013-05-07 PL PL18198081T patent/PL3501549T3/pl unknown
- 2013-05-07 HU HUE18198081A patent/HUE056327T2/hu unknown
- 2013-05-07 CN CN201380037577.3A patent/CN104994882A/zh active Pending
- 2013-05-07 RS RS20211170A patent/RS62359B1/sr unknown
- 2013-05-07 KR KR1020217004455A patent/KR20210021111A/ko not_active Ceased
- 2013-05-07 PT PT181980814T patent/PT3501549T/pt unknown
- 2013-05-07 US US13/889,275 patent/US20130323302A1/en not_active Abandoned
- 2013-05-07 LT LTEP18198081.4T patent/LT3501549T/lt unknown
- 2013-05-07 NZ NZ727516A patent/NZ727516A/en unknown
- 2013-05-07 JP JP2015512688A patent/JP6466322B2/ja active Active
- 2013-05-07 WO PCT/US2013/040011 patent/WO2013173129A2/en not_active Ceased
- 2013-05-07 SI SI201331931T patent/SI3501549T1/sl unknown
- 2013-05-07 SG SG10201609412QA patent/SG10201609412QA/en unknown
- 2013-05-07 CA CA2873628A patent/CA2873628C/en active Active
- 2013-05-07 KR KR1020147035050A patent/KR102154225B1/ko active Active
- 2013-05-07 EP EP18198081.4A patent/EP3501549B1/en active Active
- 2013-05-07 AU AU2013263159A patent/AU2013263159B2/en active Active
- 2013-05-07 SM SM20210549T patent/SMT202100549T1/it unknown
- 2013-05-07 SG SG11201407548UA patent/SG11201407548UA/en unknown
- 2013-05-07 MX MX2014013933A patent/MX362452B/es active IP Right Grant
- 2013-05-07 NZ NZ702637A patent/NZ702637A/en unknown
- 2013-05-07 RU RU2014150340A patent/RU2014150340A/ru not_active Application Discontinuation
- 2013-05-07 KR KR1020207025521A patent/KR102218067B1/ko active Active
- 2013-05-07 HR HRP20211453TT patent/HRP20211453T1/hr unknown
- 2013-05-07 ES ES18198081T patent/ES2890813T3/es active Active
- 2013-05-07 CN CN202210624338.9A patent/CN115337407A/zh active Pending
- 2013-05-07 EP EP23208659.5A patent/EP4371615A3/en active Pending
- 2013-05-07 BR BR112014028633A patent/BR112014028633A8/pt not_active Application Discontinuation
- 2013-05-07 DK DK18198081.4T patent/DK3501549T3/da active
- 2013-05-07 ES ES13791695T patent/ES2967616T3/es active Active
-
2014
- 2014-05-19 US US14/281,749 patent/US9943573B2/en active Active
- 2014-05-19 US US14/281,783 patent/US20140371438A1/en not_active Abandoned
- 2014-05-19 US US14/281,765 patent/US20140341977A1/en not_active Abandoned
- 2014-11-13 IL IL235679A patent/IL235679B/en active IP Right Grant
- 2014-11-14 MX MX2019000586A patent/MX2019000586A/es unknown
- 2014-12-09 ZA ZA2014/09025A patent/ZA201409025B/en unknown
-
2017
- 2017-10-30 JP JP2017209139A patent/JP6667486B2/ja active Active
- 2017-12-21 US US15/851,650 patent/US10004788B2/en active Active
-
2018
- 2018-04-24 US US15/961,654 patent/US20180311319A1/en not_active Abandoned
- 2018-07-31 AU AU2018211212A patent/AU2018211212B2/en active Active
-
2019
- 2019-02-20 JP JP2019028448A patent/JP2019071908A/ja not_active Withdrawn
-
2020
- 2020-12-18 JP JP2020209916A patent/JP2021045170A/ja not_active Withdrawn
-
2021
- 2021-01-15 AU AU2021200253A patent/AU2021200253A1/en not_active Abandoned
- 2021-03-25 IL IL281833A patent/IL281833A/en unknown
- 2021-05-24 US US17/328,705 patent/US20220111015A1/en active Pending
- 2021-09-15 CY CY20211100812T patent/CY1124495T1/el unknown
-
2022
- 2022-05-09 JP JP2022077005A patent/JP2022106929A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523060A5 (https=) | ||
| JP7606245B2 (ja) | 眼性新血管形成を低減するための組成物および方法 | |
| JP6667486B2 (ja) | Ａａｖ ｓｆｌｔ−１を用いたａｍｄの処置 | |
| JP7597380B2 (ja) | 対側眼へのａａｖ遺伝子治療の逐次的硝子体内投与 | |
| JP2019521990A (ja) | アフリベルセプトを含むａａｖ２バリアントを使用したａｍｄの処置 | |
| CN110423281A (zh) | 用于治疗老年性黄斑变性的融合蛋白、病毒载体和药物 | |
| AU2023202277B2 (en) | Compositions and methods for reducing ocular neovascularization | |
| HK40082757A (en) | Compositions and methods for reducing ocular neovascularization | |
| HK40115902A (en) | Compositions and methods for reducing ocular neovascularization | |
| HK40082757B (en) | Compositions and methods for reducing ocular neovascularization | |
| HK40008120B (en) | Compositions and methods for reducing ocular neovascularization | |
| HK40008120A (en) | Compositions and methods for reducing ocular neovascularization |